Select for export Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits? Details DOI 10.1080/14740338.2022.2063274 PubMed 35387542 Copy citation Copy BibTeX Expert opinion on drug safety 2022-05-31 Husain MI, Umer M, Mulsant BH PubMed Published psilocybin DepressionPTSDAddiction Other MDMA More